Resilience Care Expands Digital Oncology Platform To The United States

Resilience Care, a digital oncology company co-founded with the Gustave Roussy Institute, a global cancer center, announced its expansion into the United States. The company's platform is already in use across more than 200 clinical centers in Europe, supporting more than 35,000 consumers.

Resilience Care's platform is designed to address gaps in consumer care between clinic visits through real-time symptom tracking and adaptive treatment pathways. The system automates management of routine, low-grade symptoms through digital education and support programs, allowing clinical staff to focus on early indicators of treatment complications and intervene before symptoms . . .